Abbvie Inc
NYSE:ABBV
Abbvie Inc
Intangible Assets
Abbvie Inc
Intangible Assets Peer Comparison
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Intangible Assets
$55.6B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
40%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Intangible Assets
$26.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Intangible Assets
$32.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
34%
|
CAGR 10-Years
9%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Intangible Assets
$839.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Intangible Assets
$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Seagen Inc
NASDAQ:SGEN
|
Intangible Assets
$220.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Intangible Assets?
Intangible Assets
55.6B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Intangible Assets amounts to 55.6B USD.
What is Abbvie Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
40%
Over the last year, the Intangible Assets growth was -18%. The average annual Intangible Assets growth rates for Abbvie Inc have been -12% over the past three years , 21% over the past five years , and 40% over the past ten years .